A Clinical Trial to Evaluate the Safety and Immunogenicity of Norovirus Bivalent Vaccine

NCT04188691 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

510

Enrollment

INDUSTRY

Sponsor class

Conditions

Norwalk Gastroenteritis
Norovirus Infections

Interventions

BIOLOGICAL: Norovirus Bivalent (GI.1 / GII.4) Vaccine（low）
BIOLOGICAL: Norovirus Bivalent (GI.1 / GII.4) Vaccine（middle）
BIOLOGICAL: Norovirus Bivalent (GI.1 / GII.4) Vaccine（high）
BIOLOGICAL: Normal saline
BIOLOGICAL: Aluminum adjuvant

Sponsor

National Vaccine and Serum Institute, China

Collaborators

[object Object]
[object Object]
[object Object]